Notice ID: 2aa9fcbce5f34ff68ac403a9607fc942Special NoticeArchived
6550-- Meso Scale V-Plex 39-biomarker Diagnostic Kit Notice of Intent to Sole Source
Archived on September 3, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM MDT
- Posted
- August 12, 2026
- Notice type
- Special Notice
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 260-NETWORK CONTRACT OFFICE 20 (36C260)
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36C26026Q0952
- Notice ID
- 2aa9fcbce5f34ff68ac403a9607fc942
Description
Notice of Intent to Sole Source Requirement The Department of Veterans Affairs, VA Healthcare System, VISN 20 Contracting Activity intends to negotiate a sole source, firm-fixed price contract with Meso Scale Diagnostics LLC, 1601 Research Blvd., Rockville, MA 20850, following RFO Part 12 procedures and the authority of RFO 6.103-1, Only One Responsible Source. The procurement is for one Meso Scale V-PLEX 39-biomarker kit (5 pack) which is required to analyze the biospecimens collected as part of the Quantifying the Impacts of Frailty on Osteoporosis and Fractures in Veterans with Rheumatoid Arthritis . These kits will be used with the VA owned equipment that our collaborating staff already has access to and knowledge of. Data sets obtained from these kits will be compared with collaborators data using the same kits and analysis equipment; kits must be from the same manufacturer Meso Scale Diagnostics to be scientifically comparable. The associated NAICS code for this procurement is 325413 In-Vitro Diagnostic Substance Manufacturing. The anticipated award date: August 28, 2026. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice satisfies the requirement at RFO 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals, and no solicitation will be made available. Any responses received will only be considered for the purposes of determining the marketplace for future procurements. The Government will not pay for information submitted.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36C26026Q0952.docx
15 KBAdded in Special Notice version 3Posted
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
6550-- Meso Scale V-Plex 39-biomarker Diagnostic Kit Notice of Intent to Sole Source
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This amendment incorporates GSAM Clause 552.238-120 Economic Price Adjustment – Federal Supply Schedule Contracts (Tailored) (Sep 2024), updates Responsibility Evaluation dated October 2025, and updates the Signature Authority form dated August 2025. | 75% | Solicitation | 03/17/2024 |
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels. | 70% | Market Research | 11/27/2026 |
See attached. Thank you. | 68% | Combined Synopsis | 11/27/2026 |
Phadia 250 Reagent and Consumables | 68% | Awarded | Open |
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson). | 68% | Combined Synopsis | 11/13/2026 |
Additional Details
Solicitation Number
36C26026Q0952
Archive Date
Sep 3, 2026
Office Address
VANCOUVER, WA, 98661